317 related articles for article (PubMed ID: 34280020)
1. Epetraborole Is Active against Mycobacterium abscessus.
Ganapathy US; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0115621. PubMed ID: 34280020
[TBL] [Abstract][Full Text] [Related]
2. DS86760016, a Leucyl-tRNA Synthetase Inhibitor, Is Active against Mycobacterium abscessus.
Nguyen TQ; Heo BE; Hanh BTB; Jeon S; Park Y; Choudhary A; Lee S; Kim TH; Moon C; Min SJ; Jang J
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0156722. PubMed ID: 37212672
[TBL] [Abstract][Full Text] [Related]
3. Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
Aragaw WW; Roubert C; Fontaine E; Lagrange S; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0140021. PubMed ID: 34723632
[TBL] [Abstract][Full Text] [Related]
4. A Screening of the MMV Pandemic Response Box Reveals Epetraborole as a New Potent Inhibitor against
Kim T; Hanh BT; Heo B; Quang N; Park Y; Shin J; Jeon S; Park JW; Samby K; Jang J
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073006
[No Abstract] [Full Text] [Related]
5. A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity
Wu W; He S; Li A; Guo Q; Tan Z; Liu S; Wang X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0060122. PubMed ID: 35969055
[TBL] [Abstract][Full Text] [Related]
6.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
7. Rifabutin Is Active against Mycobacterium abscessus in Mice.
Dick T; Shin SJ; Koh WJ; Dartois V; Gengenbacher M
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767722
[TBL] [Abstract][Full Text] [Related]
8. Indole-2-Carboxamides Are Active against
Pandya AN; Prathipati PK; Hegde P; Li W; Graham KF; Mandal S; Drescher KM; Destache CJ; Ordway D; Jackson M; North EJ
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602519
[TBL] [Abstract][Full Text] [Related]
9. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
[TBL] [Abstract][Full Text] [Related]
10. Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus.
Madani A; Negatu DA; El Marrouni A; Miller RR; Boyce CW; Murgolo N; Bungard CJ; Zimmerman MD; Dartois V; Gengenbacher M; Olsen DB; Dick T
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0066922. PubMed ID: 36005813
[TBL] [Abstract][Full Text] [Related]
11. Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
Henriette Zweijpfenning SM; Chiron R; Essink S; Schildkraut J; Akkerman OW; Aliberti S; Altenburg J; Arets B; van Braeckel E; Delaere B; Gohy S; Haarman E; Lorent N; McKew G; Morgan L; Wagner D; van Ingen J; Hoefsloot W
Chest; 2022 Jul; 162(1):76-81. PubMed ID: 35063454
[No Abstract] [Full Text] [Related]
12. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
[TBL] [Abstract][Full Text] [Related]
13. Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection.
Negatu DA; González Del Río R; Cacho-Izquierdo M; Barros-Aguirre D; Lelievre J; Rullas J; Casado P; Ganapathy US; Zimmerman MD; Gengenbacher M; Dartois V; Dick T
Antimicrob Agents Chemother; 2023 Feb; 67(2):e0145922. PubMed ID: 36688684
[TBL] [Abstract][Full Text] [Related]
14. Sudapyridine (WX-081) antibacterial activity against
Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
[TBL] [Abstract][Full Text] [Related]
15. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline.
Sullivan JR; Lupien A; Kalthoff E; Hamela C; Taylor L; Munro KA; Schmeing TM; Kremer L; Behr MA
PLoS Pathog; 2021 Oct; 17(10):e1009965. PubMed ID: 34637487
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus
Sarathy JP; Zimmerman MD; Gengenbacher M; Dartois V; Dick T
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0123722. PubMed ID: 36350151
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of PBTZ169 and pretomanid against Mycobacterium avium,
Zheng L; Qi X; Zhang W; Wang H; Fu L; Wang B; Chen X; Chen X; Lu Y
Front Cell Infect Microbiol; 2023; 13():1115530. PubMed ID: 37077530
[TBL] [Abstract][Full Text] [Related]
19. Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus.
Malin JJ; Winter S; van Gumpel E; Plum G; Rybniker J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427298
[No Abstract] [Full Text] [Related]
20. [Progress in the treatment of Mycobacterium abscessus pulmonary disease].
Cui XC; Li Q; Zhou M
Zhonghua Jie He He Hu Xi Za Zhi; 2021 Mar; 44(3):257-260. PubMed ID: 33721940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
